OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Substance Abuse Treatment is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Hepatitis C treatment outcomes among patients treated in co-located primary care and addiction treatment settings	108
Substance use disorders among older populations: What role do race and ethnicity play in treatment and completion?	96
C2: editorial board	93
JSAT call for papers for special issue: Stimulant use disorder	83
Mechanisms of change in an adapted marijuana e-CHECKUP TO GO intervention on decreased college student cannabis use	77
COVID-19 and treating incarcerated populations for opioid use disorder	67
A clinical protocol of a comparative effectiveness trial of extended-release naltrexone versus extended-release buprenorphine with individuals leaving jail	66
Barriers to accessing treatment for substance use after inpatient managed withdrawal (Detox): A qualitative study	56
Community perspectives on supervised consumption sites: Insights from four U.S. counties deeply affected by opioids	53
The impact of military sexual trauma and gender on receipt of evidence-based medication treatment among veterans with opioid use disorder	51
Augmenting substance use treatment in the drug court: A pilot randomized trial of peer recovery support	51
Life satisfaction among individuals with opioid use disorder receiving extended-release naltrexone: A 12-week randomized controlled trial and a 36-week follow-up	49
A qualitative study of service engagement and unmet needs among unstably housed people who inject drugs in Massachusetts	47
Integrating substance use care into primary care for adolescents and young adults: Lessons learned	46
Perspectives on electronic portal use among patients treated with medications for opioid use disorder in primary care	42
Examining differences in retention on medication for opioid use disorder: An analysis of Ohio Medicaid data	42
Clinical symptoms and personality traits predict subpopulations of treatment-seeking substance users	41
Uncommon and preventable: Perceptions of diversion of medication for opioid use disorder in jail	41
The new services that opioid treatment programs have adopted in response to COVID-19	39
C2: editorial board	39
Views of barriers and facilitators to continuing methadone treatment upon release from jail among people receiving patient navigation services	39
What is success in treatment for opioid use disorder? Perspectives of physicians and patients in primary care settings	38
Experiences of stigma among individuals in recovery from opioid use disorder in a rural setting: A qualitative analysis	38
Sex-based differences in psychiatric symptoms and opioid abstinence during buprenorphine/naloxone treatment in adolescents with opioid use disorders	38
A randomized comparison of 4 vs. 16 weeks of psychosocial treatment for stimulant users	36

Use of non–prescribed buprenorphine in the criminal justice system: Perspectives of individuals recently released from incarceration	36
Massachusetts Justice Community Opioid Innovation Network (MassJCOIN)	35
Emergency department interventions for opioid use disorder: A synthesis of emerging models	34
What is the relapse risk during treatment? Survivor analysis of single and multiple relapse events in inpatients with alcohol use disorder as part of an observational study	32
C2: editorial board	31
Suicide safer care in behavioral health settings: A comparative analysis of perceptions, training completion, and practice between mental health and substance use disorder treatment providers	30
Serial mediation analysis of treatment-specific processes in two contrasting alcohol treatments	30